Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes

Citation
A. Bussing et al., Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes, ANTICANC R, 19(3A), 1999, pp. 1785-1790
Citations number
23
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
19
Issue
3A
Year of publication
1999
Pages
1785 - 1790
Database
ISI
SICI code
0250-7005(199905/06)19:3A<1785:IOFL(B>2.0.ZU;2-5
Abstract
Background: Fas ligand (FasL, CD95L) predominantly expressed on activated c ytotoxic T cells and NK cells triggers apoptosis in Fas receptor (Apo-1, CD 95),positive target cells. We investigated the expression of Fast, I:as and tumor necrosis factor (TNF) receptor 1 (TNF-R1, CD120a) on cultured human lymphocytes and leukemic T and B cells. Materials and Methods: Lymphocytes from six healthy individuals, from four patients with chronic lymphocytic T or B cell leukaemia, and leukemic Molt-4 cells were incubated with the apo ptosis- inducing mistletoe lectins (ML I and ML III). Results: Incubation o f differentiated lymphocytes with the ML resulted in a significant upregula tion of Fast in the surviving CD4(+) T helper cells, CD8(+) cells and CD19( +) B cells. Similarly, the TNF receptor expression increased, while the Fas molecule decreased. In contrast, Fast was not induced in leukemic cells. C onclusions: Apart from a direct induction of apoptosis in response to an in hibition of protein synthesis by the enzymic ML A chain, ML treatment may i ndirectly induce apoptosis in Fas(+) tumour cells through activated FasL(+) lymphocytes.